DarioHealth Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by DarioHealth Corp. on April 4, 2024. The filing reports on executive compensation adjustments approved by the Compensation Committee of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation changes.
Material Changes
On April 4, 2024, the Company approved the following changes to the compensation of Zvi Ben-David, Chief Financial Officer:
- Base Salary: Increased to $350,000 annually.
- Target Bonus: Maintained at up to 40% of the base salary.
- One-Time Cash Bonus: Approved a potential bonus of up to $100,000, subject to thresholds determined by the Compensation Committee.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The document serves solely to disclose the amendment to the CFO's employment agreement.
Investor Verification Checklist
- Verify the specific performance thresholds required to earn the potential $100,000 one-time cash bonus.
- Review the attached Amendment to Employment Agreement (Exhibit 10.1) for full terms and conditions.
- Confirm the impact of the salary increase on the Company's future operating expenses.